Navigation Links
Manchester leads new international study investigating Inflammatory Bowl Disease
Date:3/5/2013

The University of Manchester is leading a 12 million systems medicine research network to identify better treatments for Inflammatory Bowel Disease like Crohn's Disease.

Professor Werner Mller from the Faculty of Life Sciences is the Scientific Co-ordinator for the network called SysmedIBD. It includes universities and companies from the UK, Germany, the Netherlands, Israel and New Zealand.

The aim of the five-year project is to better understand the disease, to identify risk genes, to investigate how diet can affect IBD, to develop new biomarkers and mathematical models that can predict the best treatment for a patient. This research network is based on the systems medicine approach in which individual patient specific details are used to build better mathematical models that in turn will provide the best possible treatment suggestions for the patients.

Professor Mller says: "This systems medicine approach will lead to a better personalized diagnosis and treatment of patients with inflammatory bowel disease. We will be targeting the central pathway of inflammation in the hope that by understanding the signalling processes we can eventually manipulate them."

He continues: "IBD affects every patient differently making it very difficult to develop effective treatments. Current treatments are very expensive and many patients develop resistance to the drugs. We hope that this intense programme of research will help us to overcome the current limitations of treatments for this incurable condition."

The term IBD is used mainly to describe two diseases, Crohn's disease and ulcerative colitis. Both Crohn's disease and ulcerative colitis are chronic long-term diseases that involve inflammation of the gastrointestinal.

In the UK, IBD affects about one person in every 350. Around 100,000 people have ulcerative colitis, and 52,000 people have Crohn's disease in England.

Prof Jonathan Rhodes from the collaborating group at the University of Liverpool says "This is a great boost for Inflammatory Bowel Disease research in the UK and stands an excellent chance of leading to benefits for patients".

The scientists taking part in SysMedIBD have been meeting in Manchester to discuss the project. During the discussions they heard from the patient group Crohn's & Colitis UK about what those affected by IBD would like to see come from the work of SysMedIBD.

Professor Mller says: "We hope our findings for Inflammatory Bowel Disease will also increase our understanding of other inflammatory conditions such as arthritis."


'/>"/>

Contact: Morwenna Grills
Morwenna.Grills@manchester.ac.uk
44-161-275-2111
University of Manchester
Source:Eurekalert

Related medicine news :

1. Premium Astrology Client Care Team Leads Norah Guide to New Reviews Daily
2. Inhaled betadine leads to rare complication
3. Platypus Australia Leads The Way For Summer Fashion By Launching New Range of Children’s UV Protective Swimwear
4. Frog-in-bucket-of-milk folklore leads to potential new antibiotics
5. University of Cincinnati leads first trial on steroid and CNI withdrawal post-transplant
6. Decreased kidney function leads to decreased cognitive functioning
7. Childhood abuse leads to poor adult health
8. Healthy outlook leads to a healthy lifestyle: study
9. Lack of oxygen in cancer cells leads to growth and metastasis
10. Hopkins scientists discover how an out-of-tune protein leads to muscle demise in heart failure
11. Feeding microbials to chickens leads to mysterious immune response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
Breaking Medicine Technology: